The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson's disease

Ilona Joniec‐Maciejak(Medical University of Warsaw), Andrzej Członkowski(Medical University of Warsaw), Joanna Schwenkgrub(Centre National de la Recherche Scientifique), Anna Sznejder-Pachołek(Medical University of Warsaw), Kristof S. Bankiewicz(University of California, San Francisco), Agnieszka Ciesielska(Gladstone Institutes), Anna Członkowska(Institute of Psychiatry and Neurology), Piotr Hadaczek(University of California, San Francisco), Agnieszka Cudna(Medical University of Warsaw), Adriana Wawer(Medical University of Warsaw)
Pharmacological Reports
April 8, 2014
10.1016/j.pharep.2014.03.008
Cited by 44

Related Papers

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
|The Lancet|2012|1.2k
Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial
|The Lancet Neurology|2018|178
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
|Neurology|2021|155
Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease
|Neurology|2005|122
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
|The Lancet Neurology|2023|95